Cargando…
Treating psoriatic arthritis: how effective are TNF antagonists?
Psoriatic arthritis (PsA) is a seronegative spondyloarthropathy that commonly appears after the onset of the characteristic cutaneous lesions. This complication affects about 40% of patients with moderate to severe cutaneous disease. Analysis of synovial fluid and tissue in patients with PsA demonst...
Autores principales: | Gottlieb, Alice B, Antoni, Christian E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833458/ https://www.ncbi.nlm.nih.gov/pubmed/15228619 http://dx.doi.org/10.1186/ar1016 |
Ejemplares similares
-
Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
por: Michelon, Melissa A, et al.
Publicado: (2010) -
Musculoskeletal Imaging for Dermatologists: Techniques in the Diagnosis and Management of Psoriatic Arthritis
por: Gottlieb, Alice B., et al.
Publicado: (2021) -
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists
por: Gottlieb, Alice B., et al.
Publicado: (2022) -
Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
por: Maneiro, Jose Ramon, et al.
Publicado: (2015) -
Psoriatic arthritis: review of potential biomarkers predicting response to TNF inhibitors
por: Makos, Anaïs, et al.
Publicado: (2022)